These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 19577858

  • 1. Radiotherapy can decrease locoregional recurrence and increase survival in mastectomy patients with T1 to T2 breast cancer and one to three positive nodes with negative estrogen receptor and positive lymphovascular invasion status.
    Yang PS, Chen CM, Liu MC, Jian JM, Horng CF, Liu MJ, Yu BL, Lee MY, Chi CW.
    Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):516-22. PubMed ID: 19577858
    [Abstract] [Full Text] [Related]

  • 2. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT, Olivotto IA, Kader HA, Panades M, Speers CH, Berthelet E.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1337-47. PubMed ID: 15817335
    [Abstract] [Full Text] [Related]

  • 3. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy.
    Truong PT, Yong CM, Abnousi F, Lee J, Kader HA, Hayashi A, Olivotto IA.
    J Am Coll Surg; 2005 Jun 01; 200(6):912-21. PubMed ID: 15922205
    [Abstract] [Full Text] [Related]

  • 4. Locoregional failure 15 years after mastectomy in women with one to three positive axillary nodes with or without irradiation the significance of tumor size.
    Fodor J, Polgár C, Major T, Németh G.
    Strahlenther Onkol; 2003 Mar 01; 179(3):197-202. PubMed ID: 12627264
    [Abstract] [Full Text] [Related]

  • 5. Patients with t1 to t2 breast cancer with one to three positive nodes have higher local and regional recurrence risks compared with node-negative patients after breast-conserving surgery and whole-breast radiotherapy.
    Truong PT, Jones SO, Kader HA, Wai ES, Speers CH, Alexander AS, Olivotto IA.
    Int J Radiat Oncol Biol Phys; 2009 Feb 01; 73(2):357-64. PubMed ID: 18676091
    [Abstract] [Full Text] [Related]

  • 6. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
    Truong PT, Olivotto IA, Speers CH, Wai ES, Berthelet E, Kader HA.
    Int J Radiat Oncol Biol Phys; 2004 Mar 01; 58(3):797-804. PubMed ID: 14967436
    [Abstract] [Full Text] [Related]

  • 7. Patient subsets with T1-T2, node-negative breast cancer at high locoregional recurrence risk after mastectomy.
    Truong PT, Lesperance M, Culhaci A, Kader HA, Speers CH, Olivotto IA.
    Int J Radiat Oncol Biol Phys; 2005 May 01; 62(1):175-82. PubMed ID: 15850919
    [Abstract] [Full Text] [Related]

  • 8. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
    Truong PT, Berthelet E, Lee J, Kader HA, Olivotto IA.
    Cancer; 2005 May 15; 103(10):2006-14. PubMed ID: 15812825
    [Abstract] [Full Text] [Related]

  • 9. Quantitative molecular diagnosis of axillary drainage fluid for prediction of locoregional failure in patients with one to three positive axillary nodes after mastectomy without adjuvant radiotherapy.
    Zhang Y, Ma QY, Dang CX, Moureau-Zabotto M, Chen WK.
    Int J Radiat Oncol Biol Phys; 2006 Feb 01; 64(2):505-11. PubMed ID: 16257133
    [Abstract] [Full Text] [Related]

  • 10. T3 disease at presentation or pathologic involvement of four or more lymph nodes predict for locoregional recurrence in stage II breast cancer treated with neoadjuvant chemotherapy and mastectomy without radiotherapy.
    Garg AK, Strom EA, McNeese MD, Buzdar AU, Hortobagyi GN, Kuerer HM, Perkins GH, Singletary SE, Hunt KK, Sahin A, Schechter N, Valero V, Tucker SL, Buchholz TA.
    Int J Radiat Oncol Biol Phys; 2004 May 01; 59(1):138-45. PubMed ID: 15093909
    [Abstract] [Full Text] [Related]

  • 11. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
    Lupe K, Truong PT, Alexander C, Speers C, Tyldesley S.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):e681-8. PubMed ID: 21300456
    [Abstract] [Full Text] [Related]

  • 12. Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy.
    Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Hortobagyi GN, Buzdar AU, Valero V, Perkins GH, Schechter NR, Hunt KK, Sahin AA, Buchholz TA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):351-7. PubMed ID: 15890574
    [Abstract] [Full Text] [Related]

  • 13. Can a subgroup of node-negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?
    Yildirim E, Berberoglu U.
    Int J Radiat Oncol Biol Phys; 2007 Jul 15; 68(4):1024-9. PubMed ID: 17398017
    [Abstract] [Full Text] [Related]

  • 14. [Local relapse in young (< or = 40 years) women with breast cancer after mastectomy or breast conserving surgery: 15-year results].
    Fodor J, Mózsa E, Zaka Z, Polgár C, Major T.
    Magy Onkol; 2005 Jul 15; 49(3):203, 205-8. PubMed ID: 16249814
    [Abstract] [Full Text] [Related]

  • 15. Locoregional recurrence risks in elderly breast cancer patients treated with mastectomy without adjuvant radiotherapy.
    Truong PT, Lee J, Kader HA, Speers CH, Olivotto IA.
    Eur J Cancer; 2005 Jun 15; 41(9):1267-77. PubMed ID: 15939262
    [Abstract] [Full Text] [Related]

  • 16. Does lymphovascular invasion predict regional nodal failure in breast cancer patients with zero to three positive lymph nodes treated with conserving surgery and radiotherapy? Implications for regional radiation.
    Boutrus R, Abi-Raad R, Niemierko A, Brachtel EF, Rizk L, Kelada A, Taghian AG.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):793-8. PubMed ID: 20171799
    [Abstract] [Full Text] [Related]

  • 17. Survival benefit of post-mastectomy radiotherapy in breast carcinoma patients with T1-2 tumor and 1-3 axillary lymph node(s) metastasis.
    Duraker N, Demir D, Bati B, Yilmaz BD, Bati Y, Çaynak ZC, Sobutay E.
    Jpn J Clin Oncol; 2012 Jul 01; 42(7):601-8. PubMed ID: 22511807
    [Abstract] [Full Text] [Related]

  • 18. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
    Cheng JC, Chen CM, Liu MC, Tsou MH, Yang PS, Jian JJ, Cheng SH, Tsai SY, Leu SY, Huang AT.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):980-8. PubMed ID: 11958892
    [Abstract] [Full Text] [Related]

  • 19. Can the addition of regional radiotherapy counterbalance important risk factors in breast cancer patients with extracapsular invasion of axillary lymph node metastases?
    Gruber G, Berclaz G, Altermatt HJ, Greiner RH.
    Strahlenther Onkol; 2003 Oct 15; 179(10):661-6. PubMed ID: 14566473
    [Abstract] [Full Text] [Related]

  • 20. LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.
    Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.
    Anticancer Res; 2004 Oct 15; 24(4):2391-400. PubMed ID: 15330189
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.